GT Biopharma, Inc. — All Filings
857 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRER14C
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q/A | 10-Q/A | 0001493152-26-009127 | Mar 6, 2026 | Jun 30, 2025 |
| 10-Q/A | 10-Q/A | 0001493152-26-009126 | Mar 6, 2026 | Sep 30, 2025 |
| 10-K | 10-K | 0001493152-26-008443 | Mar 2, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-008442 | Mar 2, 2026 | Mar 1, 2026 |
| EFFECT | — | 9999999995-26-000420 | Jan 30, 2026 | — |
| 424B3 | 424B3 | 0001493152-26-004547 | Jan 30, 2026 | — |
| S-1 | S-1 | 0001493152-26-003089 | Jan 21, 2026 | — |
| 424B3 | 424B3 | 0001493152-26-000976 | Jan 8, 2026 | — |
| EFFECT | — | 9999999995-25-003476 | Dec 2, 2025 | — |
| 424B3 | 424B3 | 0001493152-25-025796 | Dec 2, 2025 | — |
| CORRESP | — | 0001493152-25-025711 | Dec 2, 2025 | — |
| 8-K | 8-K | 0001493152-25-025162 | Nov 26, 2025 | Nov 20, 2025 |
| 10-Q | 10-Q | 0001493152-25-023400 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-022631 | Nov 14, 2025 | — |
| S-1 | S-1 | 0001493152-25-019296 | Oct 24, 2025 | — |
| 8-K | 8-K | 0001493152-25-015725 | Sep 26, 2025 | Sep 25, 2025 |
| 8-K | 8-K | 0001493152-25-014684 | Sep 23, 2025 | Sep 17, 2025 |
| 4 | — | 0001641172-25-026893 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | — | 0001641172-25-026890 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | — | 0001641172-25-026894 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | — | 0001641172-25-026891 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | — | 0001641172-25-026892 | Sep 8, 2025 | Sep 4, 2025 |
| 8-K | 8-K | 0001493152-25-012479 | Aug 29, 2025 | Aug 26, 2025 |
| 10-Q | 10-Q | 0001493152-25-011971 | Aug 14, 2025 | Jun 30, 2025 |
| 3 | — | 0001641172-25-021546 | Jul 30, 2025 | Jun 10, 2025 |
| 8-K | 8-K | 0001641172-25-020847 | Jul 24, 2025 | — |
| 424B3 | 424B3 | 0001641172-25-017705 | Jul 3, 2025 | — |
| EFFECT | — | 9999999995-25-002145 | Jul 2, 2025 | — |
| CORRESP | — | 0001641172-25-017364 | Jul 1, 2025 | — |
| S-1/A | S-1/A | 0001641172-25-016977 | Jun 27, 2025 | — |
| CORRESP | — | 0001641172-25-016958 | Jun 27, 2025 | — |
| UPLOAD | — | 0000000000-25-006479 | Jun 20, 2025 | — |
| S-1 | S-1 | 0001641172-25-014752 | Jun 11, 2025 | — |
| DEFA14A | DEFA14A | 0001641172-25-014722 | Jun 11, 2025 | — |
| DEF 14A | DEF 14A | 0001641172-25-014721 | Jun 11, 2025 | — |
| 8-K | 8-K | 0001641172-25-014700 | Jun 11, 2025 | Jun 10, 2025 |
| 3 | — | 0001641172-25-013435 | Jun 3, 2025 | May 7, 2025 |
| SCHEDULE 13G/A | — | 0001683168-25-004168 | Jun 2, 2025 | — |
| PRE 14A | PRE 14A | 0001641172-25-013033 | May 30, 2025 | — |
| 3 | — | 0001641172-25-012862 | May 29, 2025 | May 8, 2025 |
| D | — | 0001641172-25-012695 | May 28, 2025 | — |
| 8-K | 8-K | 0001641172-25-012481 | May 27, 2025 | May 21, 2025 |
| D | — | 0001641172-25-012480 | May 27, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010790 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | — | 0001213900-25-043005 | May 14, 2025 | — |
| 8-K | 8-K | 0001641172-25-009941 | May 13, 2025 | May 7, 2025 |
| 8-K | 8-K | 0001641172-25-009854 | May 13, 2025 | May 12, 2025 |
| 8-K | 8-K | 0001641172-25-008682 | May 5, 2025 | Apr 29, 2025 |
| 10-K/A | — | 0001641172-25-004563 | Apr 14, 2025 | Dec 31, 2024 |
| 8-K | — | 0001641172-25-002750 | Apr 4, 2025 | Mar 31, 2025 |